植入失败
子宫内膜
耐火材料(行星科学)
富血小板血浆
医学
不育
怀孕
佐剂
血小板
内科学
泌尿科
外科
妇科
胃肠病学
生物
遗传学
天体生物学
作者
Min Kyoung Kim,Haengseok Song,Sang Woo Lyu,Woo Sik Lee
出处
期刊:Clinical and Experimental Reproductive Medicine
日期:2022-08-31
标识
DOI:10.5653/cerm.2022.05407
摘要
Refractory thin endometrium and recurrent implantation failure are among the most challenging infertility-related factors hindering successful pregnancy. Several adjuvant therapies have been investigated to increase endometrial thickness and the pregnancy rate, but the treatment effect is still minimal, and for many patients, these treatment methods can be quite costly and difficult to approach. Platelet-rich plasma (PRP) is an autologous concentration of platelets in plasma and has recently been elucidated as a better treatment option for these patients. PRP is rich in cytokines and growth factors, which are suggested to exert a regenerative effect at the level of the injured tissue. Another advantage of PRP is that it is easily obtained from the patient's own blood. We aimed to review the recent findings of PRP therapy used for patients with refractory thin endometrium and recurrent implantation failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI